Steven Keith Burke insider trades

Open-market stock purchases and sales by Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc, from SEC Form 4 filings since Jan 7, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -75%.

Recent trades

DateStockTradeValue
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$30K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$35.3K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$28.8K
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—

Companies traded

  • AKBA Akebia Therapeutics, Inc: 1 buy, 22 sales, last Feb 2, 2026
  • PRTO Proteon Therapeutics Inc: 1 buy, last Mar 15, 2019

Get free alerts when Steven Keith Burke files a new trade →